Valuation: ResMed, Inc.

Market Cap 33.4B 28.61B 26.77B 24.5B 45.99B 3,195B 46.59B 316B 123B 1,605B 125B 123B 5,309B P/E 2027 *
20.1x
P/E 2028 * 18.1x
Enterprise Value 32.45B 27.8B 26.01B 23.81B 44.68B 3,105B 45.27B 307B 120B 1,560B 122B 119B 5,159B EV / Sales 2027 *
5.58x
EV / Sales 2028 * 5.12x
Free-Float
37.57%
Yield 2027 *
1.15%
Yield 2028 * 1.26%
1 day+1.35%
1 week+3.15%
Current month+9.74%
1 month+18.24%
3 months+10.79%
6 months-10.65%
Current year-3.88%
1 week 218.66
Extreme 218.655
234.14
1 month 190.21
Extreme 190.21
234.14
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.58
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
7/8/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
5/8/26 Sell

Founder

-8,000 0.0055%
7/7/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+1.35%+3.15%-19.71%+39.56% 33.4B
+0.27%+6.97%+30.08%+18.23% 233B
+1.36%+8.10%+7.33%-12.52% 154B
+1.16%-3.98%-19.38%+32.14% 134B
+2.03%-2.82%-52.12%-0.10% 73B
-0.04%-1.98%+10.63%+17.63% 51.75B
+0.98%+2.26%-15.88%-11.61% 52.24B
+1.73%+7.05%+35.72%+33.77% 44.91B
+1.49%-0.36%+41.41%+53.72% 40.35B
+1.03%+1.53%+2.28%+8.48% 33.8B
Average +1.18%+1.90%+2.04%+17.93% 84.98B
Weighted average by Cap. +1.03%+3.01%+4.87%+14.36%

Financials

2027 *2028 *
Net sales 5.82B 4.98B 4.66B 4.27B 8.01B 557B 8.12B 55.09B 21.48B 280B 21.85B 21.37B 925B 6.2B 5.31B 4.97B 4.55B 8.53B 593B 8.65B 58.7B 22.89B 298B 23.27B 22.77B 985B
Net income 1.63B 1.4B 1.31B 1.19B 2.24B 156B 2.27B 15.42B 6.01B 78.28B 6.12B 5.98B 259B 1.78B 1.53B 1.43B 1.31B 2.45B 171B 2.49B 16.88B 6.58B 85.66B 6.69B 6.55B 283B
Net Debt -947M -811M -759M -695M -1.3B -90.63B -1.32B -8.97B -3.5B -45.53B -3.56B -3.48B -151B -1.69B -1.44B -1.35B -1.24B -2.32B -161B -2.35B -15.97B -6.23B -81.05B -6.33B -6.19B -268B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
11,370
Date Price Change Volume
21/08/26 US$231.52 +1.35% 1,725,345
20/08/26 US$228.44 -0.96% 1,285,692
19/08/26 US$230.65 +4.85% 1,209,808
18/08/26 US$219.98 -0.18% 1,295,889
17/08/26 US$220.37 -1.82% 1,453,880
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
231.52USD
Average target price
245.50USD
Spread / Average Target
+6.04%

Quarterly revenue - Rate of surprise